62 related articles for article (PubMed ID: 24619961)
1. Berbamine enhances the antineoplastic activity of gemcitabine in pancreatic cancer cells by activating transforming growth factor-β/Smad signaling.
Jin X; Wu Y
Anat Rec (Hoboken); 2014 May; 297(5):802-9. PubMed ID: 24619961
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol.
Zhou L; Qi L; Jiang L; Zhou P; Ma J; Xu X; Li P
AAPS J; 2014 Mar; 16(2):246-57. PubMed ID: 24424498
[TBL] [Abstract][Full Text] [Related]
3. Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs.
Yang X; Xu Y; Brooks A; Guo B; Miskimins KW; Qian SY
Free Radic Biol Med; 2016 Aug; 97():342-350. PubMed ID: 27368132
[TBL] [Abstract][Full Text] [Related]
4. Small Molecule APY606 Displays Extensive Antitumor Activity in Pancreatic Cancer via Impairing Ras-MAPK Signaling.
Guo N; Liu Z; Zhao W; Wang E; Wang J
PLoS One; 2016; 11(5):e0155874. PubMed ID: 27223122
[TBL] [Abstract][Full Text] [Related]
5. The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF-β receptor plus dual checkpoint inhibition maintains antitumor immune cells.
Rana M; Kansal R; Chaib M; Teng B; Morrrison M; Hayes DN; Stanfill AG; Shibata D; Carson JA; Makowski L; Glazer ES
Mol Carcinog; 2022 Jun; 61(6):549-557. PubMed ID: 35319799
[TBL] [Abstract][Full Text] [Related]
6. Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy.
Qiang L; Hoffman MT; Ali LR; Castillo JI; Kageler L; Temesgen A; Lenehan P; Wang SJ; Bello E; Cardot-Ruffino V; Uribe GA; Yang A; Dougan M; Aguirre AJ; Raghavan S; Pelletier M; Cremasco V; Dougan SK
Gastroenterology; 2023 Oct; 165(4):874-890.e10. PubMed ID: 37263309
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
[TBL] [Abstract][Full Text] [Related]
8. Combination Treatment of Biochanin A and Atorvastatin Alters Mitochondrial Bioenergetics, Modulating Cell Metabolism and Inducing Cell Cycle Arrest in Pancreatic Cancer Cells.
Desai V; Tadinada SM; Shaghaghi H; Summer R; Lai JCK; Bhushan A
Anticancer Res; 2024 Jun; 44(6):2307-2323. PubMed ID: 38821627
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin Treatment Inducing Apoptosis in Human Pancreatic Cancer Cells by Inhibiting Cholesterol Rafts in Plasma Membrane and Mitochondria.
Gyoten M; Luo Y; Fujiwara-Tani R; Mori S; Ogata R; Kishi S; Kuniyasu H
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069135
[TBL] [Abstract][Full Text] [Related]
10. Systems Pharmacodynamic Model of Combined Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways.
Miao X; Koch G; Shen S; Wang X; Li J; Shen X; Qu J; Straubinger RM; Jusko WJ
J Pharm Sci; 2024 Jan; 113(1):235-245. PubMed ID: 37918792
[TBL] [Abstract][Full Text] [Related]
11. Targeting mitochondrial transcription factor A sensitizes pancreatic cancer cell to gemcitabine.
Wang W; Jiang CF; Yin HS; Gao S; Yu BP
Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):519-527. PubMed ID: 37002014
[TBL] [Abstract][Full Text] [Related]
12. The combination of intravenous Reolysin and gemcitabine induces reovirus replication and endoplasmic reticular stress in a patient with KRAS-activated pancreatic cancer.
Mahalingam D; Patel S; Nuovo G; Gill G; Selvaggi G; Coffey M; Nawrocki ST
BMC Cancer; 2015 Jul; 15():513. PubMed ID: 26156229
[TBL] [Abstract][Full Text] [Related]
13. Systems pharmacodynamic model of combined gemcitabine and trabectedin in pancreatic cancer cells. Part I.Çô Effects on signal transduction pathways related to tumor growth.
Miao X; Shen S; Koch G; Wang X; Li J; Shen X; Qu J; Straubinger RM; Jusko WJ
J Pharm Sci; 2024 Jan; 113(1):214-227. PubMed ID: 38498417
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of nanosecond pulsed electric fields combined with low concentration of gemcitabine on human oral squamous cell carcinoma in vitro.
Wang J; Guo J; Wu S; Feng H; Sun S; Pan J; Zhang J; Beebe SJ
PLoS One; 2012; 7(8):e43213. PubMed ID: 22927951
[TBL] [Abstract][Full Text] [Related]
15. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.
Mihailidou C; Papakotoulas P; Papavassiliou AG; Karamouzis MV
Oncotarget; 2018 Feb; 9(12):10360-10374. PubMed ID: 29535812
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells.
Larson AC; Knoche SM; Brumfield GL; Doty KR; Gephart BD; Moore-Saufley PR; Solheim JC
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542184
[TBL] [Abstract][Full Text] [Related]
17. Rutinosides-derived from Sarocladium strictum 6-O-α-rhamnosyl-β-glucosidase show enhanced anti-tumoral activity in pancreatic cancer cells.
Weiz G; González AL; Mansilla IS; Fernandez-Zapico ME; Molejón MI; Breccia JD
Microb Cell Fact; 2024 May; 23(1):133. PubMed ID: 38720294
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and Therapeutic Potential of Berbamine: A Potent Alkaloid from Genus Berberis.
Muhammad G; Hussain MA; Shafiq Z; Ashraf A; Shafique U; Khan A; Khalid A; Hussain J; Al-Harrasi A
Curr Top Med Chem; 2024 Apr; ():. PubMed ID: 38685780
[TBL] [Abstract][Full Text] [Related]
19. CuO-TiO
Elderdery AY; Alzahrani B; Hamza SMA; Mostafa-Hedeab G; Mok PL; Subbiah SK
Bioinorg Chem Appl; 2022; 2022():9602725. PubMed ID: 36164585
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profiling of a berbamine derivative for lymphoma treatment.
Xu S; Wu S; Zhang M; Xie J; Lin M; Jin L; Zhang J; Wang Y; Fan M; Fang Z; Li W; Ouyang C; Kwon D; Que N; Li Z; Mao J; Chen H; Harris J; Wu X; Wu J; Yin H; Chan WC; Horne D; Huang W
Blood Adv; 2024 Jan; 8(2):309-323. PubMed ID: 37967356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
